Bilaketaren emaitzak - Yasuhiro Koh
- Erakusten 1 - 20 emaitzak -- 32
- Go to Next Page
-
1
Combined Treatment with Erlotinib and a Transforming Growth Factor-β Type I Receptor Inhibitor Effectively Suppresses the Enhanced Motility of Erlotinib-Resistant Non–Small-Cell Lu... nork Masakuni Serizawa, Toshiaki Takahashi, Nobuyuki Yamamoto, Yasuhiro Koh
Argitaratua 2013Artigo -
2
-
3
Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib (“Iressa”) and the DNA topoisomerase I inhibitor CPT‐11 (irinotecan) in human colorectal cancer cells... nork Fumiaki Koizumi, Fumihiko Kanzawa, Yutaka Ueda, Yasuhiro Koh, Shoji Tsukiyama, Fumiko Taguchi, Tomohide Tamura, Nagahiro Saijo, Kazuto Nishio
Argitaratua 2003Artigo -
4
P-Glycoprotein Mediates Efflux Transport of Darunavir in Human Intestinal Caco-2 and ABCB1 Gene-Transfected Renal LLC-PK1 Cell Lines nork Hiromi Fujimoto, Maiko Higuchi, Hiroshi Watanabe, Yasuhiro Koh, Arun K. Ghosh, Hiroaki Mitsuya, Naomi Tanoue, Akinobu Hamada, Hideyuki Saito
Argitaratua 2009Artigo -
5
Design and Synthesis of Potent HIV-1 Protease Inhibitors Incorporating Hexahydrofuropyranol-Derived High Affinity P<sub>2</sub> Ligands: Structure−Activity Studies and Biological E... nork Arun K. Ghosh, Bruno D. Chapsal, Abigail Baldridge, Melinda Steffey, D. Eric Walters, Yasuhiro Koh, Masayuki Amano, Hiroaki Mitsuya
Argitaratua 2010Artigo -
6
Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma nork Kyoichi Kaira, Masakuni Serizawa, Yasuhiro Koh, Toshiaki Takahashi, Hirofumi Hanaoka, Noboru Oriuchi, Masahiro Endo, Haruhiko Kondo, Takashi Nakajima, Nobuyuki Yamamoto
Argitaratua 2012Artigo -
7
Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir nork Hironori Hayashi, Nobutoki Takamune, Takashi Nirasawa, Manabu Aoki, Yoshihiko Morishita, Debananda Das, Yasuhiro Koh, Arun K. Ghosh, Shogo Misumi, Hiroaki Mitsuya
Argitaratua 2014Artigo -
8
A Novel Bis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI), GRL-98065, Is Potent against Multiple-PI-Resistant Human Immunodeficiency Virus In Vitro nork Masayuki Amano, Yasuhiro Koh, Debananda Das, Jianfeng Li, Sofiya Leschenko, Yuan-Fang Wang, Péter Boross, Irene T. Weber, Arun K. Ghosh, Hiroaki Mitsuya
Argitaratua 2007Artigo -
9
<i>In Vitro</i> Selection of Highly Darunavir-Resistant and Replication-Competent HIV-1 Variants by Using a Mixture of Clinical HIV-1 Isolates Resistant to Multiple Conventional Pr... nork Yasuhiro Koh, Masayuki Amano, Tomomi Towata, Matthew Danish, Sofiya Leshchenko-Yashchuk, Debananda Das, Maki Nakayama, Yasushi Tojo, Arun K. Ghosh, Hiroaki Mitsuya
Argitaratua 2010Artigo -
10
-
11
Differential Effects of Human Immunodeficiency Virus Type 1 Capsid and Cellular Factors Nucleoporin 153 and LEDGF/p75 on the Efficiency and Specificity of Viral DNA Integration nork Yasuhiro Koh, Xiaolin Wu, Andrea L. Ferris, Kenneth A. Matreyek, Steven J. Smith, Kyeongeun Lee, Vineet N. KewalRamani, Stephen H. Hughes, Alan Engelman
Argitaratua 2012Artigo -
12
Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro nork Kenji Maeda, Hirotomo Nakata, Yasuhiro Koh, Toshikazu Miyakawa, Hiromi Ogata, Yoshikazu Takaoka, Shiro Shibayama, Kenji Sagawa, Daikichi Fukushima, Joseph Moravek, Yoshio Koyanagi, Hiroaki Mitsuya
Argitaratua 2004Artigo -
13
Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab nork Koichi Sato, Hiroaki Akamatsu, Eriko Murakami, Seigo Sasaki, Kuninobu Kanai, Atsushi Hayata, Nahomi Tokudome, Keiichiro Akamatsu, Yasuhiro Koh, Hiroki Ueda, Masanori Nakanishi, Nobuyuki Yamamoto
Argitaratua 2017Artigo -
14
Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer nork Yasuhiro Koh, Satomi Yagi, Hiroaki Akamatsu, Kuninobu Kanai, Atsushi Hayata, Nahomi Tokudome, Keiichiro Akamatsu, Masayuki Higuchi, Hisashige Kanbara, Masanori Nakanishi, Hiroki Ueda, Nobuyuki Yamamoto
Argitaratua 2019Artigo -
15
Conditional Overexpression of Active Transforming Growth Factor β1 <b> <i>In vivo</i> </b> Accelerates Metastases of Transgenic Mammary Tumors nork Rebecca S. Muraoka-Cook, Hirokazu Kurokawa, Yasuhiro Koh, James T. Forbes, L. Renee Roebuck, Mary Helen Barcellos‐Hoff, Susan E. Moody, Lewis A. Chodosh, Carlos L. Arteaga
Argitaratua 2004Artigo -
16
Potent Inhibition of HIV-1 Replication by Novel Non-peptidyl Small Molecule Inhibitors of Protease Dimerization nork Yasuhiro Koh, Shintaro Matsumi, Debananda Das, Masayuki Amano, David A. Davis, Jianfeng Li, Sofiya Leschenko, Abigail Baldridge, Tatsuo Shioda, Robert Yarchoan, Arun K. Ghosh, Hiroaki Mitsuya
Argitaratua 2007Artigo -
17
Activity against Human Immunodeficiency Virus Type 1, Intracellular Metabolism, and Effects on Human DNA Polymerases of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine nork Hirotomo Nakata, Masayuki Amano, Yasuhiro Koh, Eiichi Kodama, Guangwei Yang, Christopher M. Bailey, Satoru Kohgo, Hiroyuki Hayakawa, Masao Matsuoka, Karen S. Anderson, Yung-Chi Cheng, Hiroaki Mitsuya
Argitaratua 2007Artigo -
18
Design of HIV-1 Protease Inhibitors with Pyrrolidinones and Oxazolidinones as Novel P1′-Ligands To Enhance Backbone-Binding Interactions with Protease: Synthesis, Biological Evalua... nork Arun K. Ghosh, Sofiya Leshchenko-Yashchuk, David D. Anderson, Abigail Baldridge, Marcus W. Noetzel, Heather B. Miller, Yunfeng Tie, Yuan-Fang Wang, Yasuhiro Koh, Irene T. Weber, Hiroaki Mitsuya
Argitaratua 2009Artigo -
19
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter nork Masaru Watanabe, Hirotsugu Kenmotsu, Ryo Ko, Kazushige Wakuda, Akira Ono, Hisao Imai, Tetsuhiko Taira, Tateaki Naito, Haruyasu Murakami, Masato Abe, Masahiro Endo, Takashi Nakajima, Yasuhiro Koh, Toshiaki Takahashi
Argitaratua 2018Artigo -
20
Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation nork Kellie A. Jurado, Hao Wang, Alison Slaughter, Lei Feng, Jacques J. Kessl, Yasuhiro Koh, Weifeng Wang, Allison Ballandras-Colas, Pratiq A. Patel, James R. Fuchs, Mamuka Kvaratskhelia, Alan Engelman
Argitaratua 2013Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Biology
Biochemistry
Medicine
Internal medicine
Cancer
Cancer research
Chemistry
Oncology
Virology
Lung cancer
Antiretroviral therapy
Enzyme
Genetics
Viral load
Virus
Gene
HIV-1 protease
Protease
Receptor
Immunology
In vitro
Pathology
Cell biology
Epidermal growth factor receptor
Mutation
Viral replication
Colorectal cancer
Darunavir
Gefitinib
Immunotherapy